Cargando…

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis

OBJECTIVES: The characteristics and prognostic factors of small-cell lung cancer (SCLC) patients with bone metastases at first diagnosis have scarcely been reported. This study aimed to analyze the prognostic factors of these patients and to develop a scoring system for survival to provide evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Linlin, Xu, Liming, Yuan, Zhiyong, Wang, Zhongqiu, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859228/ https://www.ncbi.nlm.nih.gov/pubmed/31763163 http://dx.doi.org/10.1016/j.jbo.2019.100265

Ejemplares similares

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
por: Luo, Jing, et al.
Publicado: (2017)

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
por: Liu, Zhiyan, et al.
Publicado: (2018)

The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis
por: Ma, Jintao, et al.
Publicado: (2022)

Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers
por: Meng, Chunliu, et al.
Publicado: (2021)

Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system
por: Yu, Xuyao, et al.
Publicado: (2020)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2013)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients
por: Zhang, Baozhong, et al.
Publicado: (2017)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
por: Zhang, Baozhong, et al.
Publicado: (2016)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
por: Qi, Jing, et al.
Publicado: (2019)

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients
por: Qi, Jing, et al.
Publicado: (2021)

Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues
por: Xuyao, Yu, et al.
Publicado: (2020)

Influence of different image-guided tracking methods upon the local efficacy of CyberKnife treatment in lung tumors
por: Guo, Yihang, et al.
Publicado: (2015)

Altered diversity and composition of the gut microbiome in patients with cervical cancer
por: Wang, Zhongqiu, et al.
Publicado: (2019)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of bone metastases
por: Pu, Feifei, et al.
Publicado: (2023)

Disparities in survival following surgery among patients with different histological types of N2-III non-small cell lung cancer: a Surveillance, Epidemiology and End Results (SEER) database analysis
por: Jin, Gang, et al.
Publicado: (2020)

Risk Prediction Model for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Thoracic Radiotherapy May Not Prolong Survival in High-Risk patients
por: Meng, Chunliu, et al.
Publicado: (2022)

Hepatoid Adenocarcinoma Of The Lung Metastasizing To The Gingiva
por: Wang, Chunhua, et al.
Publicado: (2019)

Establishment of a regression model of bone metabolism markers for the diagnosis of bone metastases in lung cancer
por: Zhu, Zhongliang, et al.
Publicado: (2021)

Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases
por: Li, Ming, et al.
Publicado: (2023)

Adverse impact of bone metastases on clinical outcomes of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Li, Xing, et al.
Publicado: (2020)

Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
por: Lin, Runlong, et al.
Publicado: (2015)

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
por: Wang, Xin, et al.
Publicado: (2018)

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
por: Daniele, Santini, et al.
Publicado: (2015)

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021)

Efficacy of Paclitaxel Combined with Kanglaite Injection in Treatment of Bone Metastases of Lung Cancer
por: CAO, Liming, et al.
Publicado: (2019)

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2016)

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2018)

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Mechanisms, Diagnosis and Treatment of Bone Metastases
por: Ban, Jozef, et al.
Publicado: (2021)

Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.
por: Skov, B. G., et al.
Publicado: (1992)

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
por: Santini, Daniele, et al.
Publicado: (2016)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
por: Landi, Lorenza, et al.
Publicado: (2019)

Bone metastases in non-small cell lung cancer: a narrative review
por: Knapp, Brendan J., et al.
Publicado: (2022)

The landscape of small cell lung cancer metastases: Organ specificity and timing
por: Megyesfalvi, Zsolt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mkri7mf97blkg9ri7524k1upps